Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Pajaniappan, Mohanasundari ^a   Glober, Nancy K ^a   Kennard, Simone ^a   Liu, Hua ^a   Zhao, Ning ^a,b   Lilly, Brenda ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Coculture; NOTCH3; Vascular smooth muscle cells

Indexed keywords

APOLIPOPROTEIN D; JAGGED1; NOTCH RECEPTOR; NOTCH3 RECEPTOR; TUBULIN;

ARTICLE; CELL; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MURAL CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANALYSIS OF VARIANCE; APOLIPOPROTEINS D; CALCIUM-BINDING PROTEINS; CELL ADHESION; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROBLASTS; FOCAL ADHESIONS; GENES, REPORTER; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PARACRINE COMMUNICATION; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 80052305772     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00116.2011     Document Type: Article

References (40)

1. Aho S. Soluble form of Jagged1: unique product of epithelial keratinocytes and a regulator of keratinocyte differentiation. J Cell Biochem 92: 1271-1281, 2004.
2. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 97: 512-523, 2005.
3. Baron M. An overview of the Notch signalling pathway. Semin Cell Dev Biol 14: 113-119, 2003.
4. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464, 2005.
5. Boyles JK, Notterpek LM, Anderson LJ. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem 265: 17805-17815, 1990.
6. Burridge K, Fath K. Focal contacts: transmembrane links between the extracellular matrix and the cytoskeleton. Bioessays 10: 104-108, 1989.
7. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438: 932-936, 2005.
8. Curry MD, McConathy WJ, Alaupovic P. Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta 491: 232-241, 1977.
9. Darland DC, D'Amore PA. Cell-cell interactions in vascular development. Curr Top Dev Biol 52: 107-149, 2001.
10. Do Carmo S, Seguin D, Milne R, Rassart E. Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 277: 5514-5523, 2002.
11. Gaengel K, Genove G, Armulik A, Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29: 630-638, 2009.
12. Ganfornina MD, Do Carmo S, Lora JM, Torres-Schumann S, Vogel M, Allhorn M, Gonzalez C, Bastiani MJ, Rassart E, Sanchez D. Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress. Aging Cell 7: 506-515, 2008.
13. Ganfornina MD, Do Carmo S, Martinez E, Tolivia J, Navarro A, Rassart E, Sanchez D. ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia 58: 1320-1334, 2010.
14. Hull-Thompson J, Muffat J, Sanchez D, Walker DW, Benzer S, Ganfornina MD, Jasper H. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. PLoS Genet 5: e1000460, 2009.
15. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 5, Suppl 1: 32-40, 2007.
16. Kennard S, Liu H, Lilly B. Transforming growth factor-beta (TGF-1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem 283: 1324-1333, 2008.
17. Lambert J, Provost PR, Marcel YL, Rassart E. Structure of the human apolipoprotein D gene promoter region. Biochim Biophys Acta 1172: 190-192, 1993.
18. Lane DM, McConathy WJ. Factors affecting the lipid and apolipoprotein levels of cord sera. Pediatr Res 17: 83-91, 1983.
19. Leung WC, Lawrie A, Demaries S, Massaeli H, Burry A, Yablonsky S, Sarjeant JM, Fera E, Rassart E, Pickering JG, Rabinovitch M. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration. Circ Res 95: 179-186, 2004.
20. Lilly B, Kennard S. Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling. Physiol Genomics 36: 69-78, 2009.
21. Liu H, Kennard S, Lilly B. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ Res 104: 466-475, 2009.
22. Liu Z, Chang GQ, Leibowitz SF. Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis. FASEB J 15: 1329-1331, 2001.
23. Louvi A, Arboleda-Velasquez JF, Artavanis-Tsakonas S. CADASIL: a critical look at a Notch disease. Dev Neurosci 28: 5-12, 2006.
24. Muffat J, Walker DW. Apolipoprotein D: an overview of its role in aging and age-related diseases. Cell Cycle 9: 269-273, 2010.
25. Nix DA, Fradelizi J, Bockholt S, Menichi B, Louvard D, Friederich E, Beckerle MC. Targeting of zyxin to sites of actin membrane interaction and to the nucleus. J Biol Chem 276: 34759-34767, 2001.
26. Perdomo G, Dong H. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Albany NY) 1: 17-27, 2009.
27. Provost PR, Marcel YL, Milne RW, Weech PK, Rassart E. Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett 290: 139-141, 1991.
28. Provost PR, Villeneuve L, Weech PK, Milne RW, Marcel YL, Rassart E. Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J Lipid Res 32: 1959-1970, 1991.
29. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R. Apolipoprotein D. Biochim Biophys Acta 1482: 185-198, 2000.
30. Sanchez D, Ganfornina MD, Martinez S. Expression pattern of the lipocalin apolipoprotein D during mouse embryogenesis. Mech Dev 110: 225-229, 2002.
31. Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ, Ganfornina MD, Hull-Thompson J, Muffat J, Sanchez D, Walker DW, Benzer S, Ganfornina MD, Jasper H. Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Control of metabolic homeostasis by stress signaling is mediated by the lipocalin NLaz. Curr Biol 16: 680-686, 2006.
32. Sarjeant JM, Lawrie A, Kinnear C, Yablonsky S, Leung W, Massaeli H, Prichett W, Veinot JP, Rassart E, Rabinovitch M. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Arterioscler Thromb Vasc Biol 23: 2172-2177, 2003.
33. Smith KM, Lawn RM, Wilcox JN. Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. J Lipid Res 31: 995-1004, 1990.
34. Soiland H, Skaland I, Varhaug JE, Korner H, Janssen EA, Gudlaugsson E, Baak JP, Soreide JA. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer-possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncol 48: 514-521, 2009.
35. Spector D, Goldman R, Leinwand L. Cells: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1998, p. 98-110.
36. Spreyer P, Schaal H, Kuhn G, Rothe T, Unterbeck A, Olek K, Muller HW. Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J 9: 2479-2484, 1990.
37. Vijayaraghavan S, Hitman GA, Kopelman PG. Apolipoprotein-D polymorphism: a genetic marker for obesity and hyperinsulinemia. J Clin Endocrinol Metab 79: 568-570, 1994.
38. Walker DW, Muffat J, Rundel C, Benzer S. Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr Biol 16: 674-679, 2006.
39. Weech PK, Provost P, Tremblay NM, Camato RN, Milne RW, Marcel YL, Rassart E. Apolipoprotein D-an atypical apolipoprotein. Prog Lipid Res 30: 259-266, 1991.
40. Xu W, Baribault H, Adamson ED. Vinculin knockout results in heart and brain defects during embryonic development. Development 125: 327-337, 1998.